HomeADIL • NASDAQ
add
Adial Pharmaceuticals Inc
Previous close
$0.73
Day range
$0.70 - $0.73
Year range
$0.58 - $3.00
Market cap
4.67M USD
Avg Volume
68.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.94M | 8.80% |
Net income | -2.07M | -7.83% |
Net profit margin | — | — |
Earnings per share | -0.15 | 59.46% |
EBITDA | -1.94M | -8.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.75M | 32.66% |
Total assets | 5.04M | 6.49% |
Total liabilities | 975.86K | 49.42% |
Total equity | 4.07M | — |
Shares outstanding | 6.57M | — |
Price to book | 1.16 | — |
Return on assets | -82.54% | — |
Return on capital | -97.51% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.07M | -7.83% |
Cash from operations | -1.45M | -18.92% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.45M | -157.89% |
Free cash flow | -779.80K | -198.77% |
About
Founded
2010
Headquarters
Website
Employees
5
